@article{ref1,
title="Correlates and trends in youth co-use of marijuana and tobacco in the United States, 2005-2014",
journal="Drug and alcohol dependence",
year="2018",
author="Schauer, Gillian L. and Peters, Erica N.",
volume="185",
number="",
pages="238-244",
abstract="BACKGROUND: Past-month marijuana and tobacco use (co-use) are increasing among U.S. adults, but little is known about the prevalence of co-use among U.S. youth. This study uses nationally representative data to assess the prevalence, correlates, and trends in co-use of marijuana and tobacco, tobacco-only use, and marijuana-only use among U.S. youth. <br><br>METHODS: Data came from 176,245 youth ages 12-17 who responded to the National Survey on Drug Use and Health - a nationally representative, household interview survey - between 2005 and 2014. Prevalence, demographics and substance use characteristics from 2013 to 14 were assessed across three groups: past-month users of marijuana and tobacco (co-users), past-month tobacco-only users, and past-month marijuana-only users. Multinomial logistic regression was used to assess demographic correlates of each group. Linear and quadratic trends were assessed from 2005 to 2014 using logistic regression with orthogonal polynomials. <br><br>RESULTS: In 2013-14, 5.4% of youth reported past-month co-use of tobacco and marijuana, 2.2% reported marijuana-only use, and 3.9% reported tobacco-only use. Co-use was associated with higher prevalence of past year marijuana dependence (vs. marijuana-only users), and higher past-month risky alcohol and other illicit drug use (vs. both tobacco and marijuana-only use groups). Co-use did not increase significantly between 2005 and 2014; tobacco-only use declined, and marijuana-only use increased. <br><br>CONCLUSIONS: Co-use of marijuana and tobacco is more prevalent than tobacco-only or marijuana-only use in U.S. youth. Given changing tobacco and marijuana policies, ongoing surveillance and studies that seek to increase our understanding of co-use behaviors in youth are critical.<br><br>Copyright © 2018 Elsevier B.V. All rights reserved.<p /> <p>Language: en</p>",
language="en",
issn="0376-8716",
doi="10.1016/j.drugalcdep.2017.12.007",
url="http://dx.doi.org/10.1016/j.drugalcdep.2017.12.007"
}